Upjohn pharmacist reimbursement programs halted by FDA.
D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005905:Glyburide / Q000191:economics*; D006801:Humans; D010595:Pharmacists / Q000191:economics*; D012052:Reimbursement, Incentive / Q000331:legislation & jurisprudence*; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
D005905:Glyburide